CompoAtlas

TWINLAB® Aller-D Caps

Natural health product licensed in Canada

Licence holder
Twinlab Corporation
NPN or DIN-HM
80005355
Status
Inactive licence
Licence date
26 March 2008
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Officinale

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Vitamine D

Potency : 400 UI

10 mcg20 µg

Non-medicinal ingredients

Oryza sativa, triglycérides à chaînes moyennes, silice, Gélatine, Fécule de pommes de terre, Eau purifiée, Stéarate de magnésium

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 years2 Capsule1 Tous les jours
Nourrissonsmaximum: 12 monthsminimum: 1 Capsule ; maximum: 2 Capsule1 Tous les jours
Adolescentesminimum: 9 years ; maximum: 18 yearsminimum: 1 Capsule ; maximum: 2 Capsule1 Tous les jours
Enfantsminimum: 1 year ; maximum: 8 yearsminimum: 1 Capsule ; maximum: 2 Capsule1 Tous les jours

Uses authorised in Canada

Helps to maintain good health. Helps in the development and maintenance of bones and teeth. Helps in the absorption and use of calcium and phosphorus. Helps to prevent Vitamin D deficiency.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80005355

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line